A new brace targets Achilles tendonitis, plantar fasciitis, and more than 30 other foot and ankle disorders.
With TCT in full swing, Or Yehuda, Israel-based Cardiovalve is launching the AHEAD US Multicenter Study, and jumping head first into the quickly growing TMVR market.
The Menlo Park, CA-based company said it has raised $10 million in a series B to help support a clinical study of its technology.
More than two years after Medtronic first hitched its wagon to Mazor Robotics, the pair is making it official through an acquisition valued at $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired.
The company’s Phoenix device is a bioelectric medicine that has the potential to treat functional diseases such as type-2 diabetes, hypertension, and gastroesophageal reflux disease.
Financings, joint ventures, and clearances continue to drive the quickly growing surgical robotics market.
LivaNova is launching a pivotal study that will look at how stimulation of the vagus nerve with the VITARIA device can help treat heart failure patients.
The Los Alamitos, CA-based company has received FDA clearance for the Infrared Heat Therapy Pain Relief wearable.
The Cupertino, CA-based company garnered a lot of attention for incorporating an ECG into the next iteration of the Apple Watch and now analysts along with industry experts are sounding off on the technology’s potential impact.
As patients and advocates mark National Pain Awareness Month, keep an eye on these potential solutions.
The decision to suspend its TempSure Vitalia system based on FDA concerns about vaginal rejuvenation procedures is expected to hurt Hologic's fourth-quarter revenue projections by $15 million.
In July, AngioDynamics’ CEO promised the company would be turning toward M&A to enhance growth opportunities.
The company's technology has been hailed as the first major change in breast tissue expansion in almost 40 years.